GL1X · GenesisL1 explorer

MolNFT v1 · #165954 · protein

N123-VRC34.05 HIV neutralizing antibody in complex with HIV fusion peptide residue 512-519

6UBI · VRC34.05 heavy chain: “N123-VRC34.05 HIV neutralizing antibody in complex with HIV fusion peptide residue 512-519”. X-ray diffraction, 7 pockets (best druggability 0.73). MolNFT v1 #165954 on GenesisL1: 3D structure, binding sites…

PDB
6UBI
Type
protein
Length
875 residues
Chains
6
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
VRC34.05 heavy chain; VRC34.05 light chain; HIV fusion peptide 512-519
UniProt
P0DOX5, Q6GMX0
Pockets
7 · best druggability 0.73

Structure

x-ray diffraction · 4 distinct chains · 7% helix, 50% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AVRC34.05 heavy chainprotein2157% helix, 51% strandP0DOX5
B, EVRC34.05 light chainprotein2126% helix, 50% strandQ6GMX0
C, FHIV fusion peptide 512-519protein80% helix, 0% strand—
DVRC34.05 heavy chainprotein2207% helix, 50% strandP0DOX5

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111260.730.7698empty
26300.640.7559empty
34250.580.7555empty
44570.580.7455empty
5520.460.8523empty

Interfaces

10 interfaces between chains.

  • D–E · 1749 Ų buried · 12 hydrogen bonds · protein-protein
  • A–B · 1738 Ų buried · 13 hydrogen bonds · protein-protein
  • D–F · 465 Ų buried · 8 hydrogen bonds · protein-protein
  • A–C · 460 Ų buried · 7 hydrogen bonds · protein-protein
  • A–E · 249 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 8 disulfide (disulfide).

Compared structures

  • 6UBI · N123-VRC34.05 HIV neutralizing antibody in complex with HIV fusion peptide residue 512-519 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.